A burgeoning literature supports the ability of estrogens to signal to multiple cell types in the microenvironments of ER+ breast cancers, which would include not only tumor cells, but also CAFs and immune populations, supported by the widespread distribution of the various estrogen receptors (Figure 1). This evidence concerns the gene ESR1 and breast carcinoma.